Black & Veatch was recently selected by the U.S. Defense Threat Reduction Agency (DTRA) to continue the company’s work in Ukraine to enhance the partner nation’s sustainable capacity to detect, diagnose, report, and respond to infectious disease outbreaks. Under the contract, Black & Veatch will support implementation of the agency’s Cooperative Biological Engagement Program (CBEP) with the Government of Ukraine. This award has a potential contract value of about $85 million over five years.
The CBEP program enhances the animal health system by providing modern lab facilities, equipment and training. Black & Veatch is completing support for similar program activities it began in 2008 to strengthen the human health system in Ukraine.
“We will continue to provide our client with best practices in preventing the spread of biological weapons, technology and pathogens,” said Bill Van Dyke, President, Federal Services, Black & Veatch. “We understand the client’s needs and goals required for successful, sustainable results.”
In 2010, Black & Veatch completed Ukraine’s first Bio-Safety Level 3 (BSL-3) laboratory under a contract with the DTRA. It is the first BSL-3 laboratory commissioned for the agency. The facility enhances the existing biosurveillance system to detect and respond to bioterrorism and potential pandemics.
About Black & Veatch
Black & Veatch is an employee-owned, global leader in building Critical Human Infrastructure™ in Energy, Water, Telecommunications and Government Services. Since 1915, we have helped our clients improve the lives of people in over 100 countries through consulting, engineering, construction, operations and program management. Our revenues in 2011 were US$2.6 billion. Follow us on www.bv.com and in social media.Business Wire
Last updated on: 08/10/2012